Global Kidney Cancer Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

GLO2773811
135 Pages
September 2018
Pharmaceuticals

Download Sample Get Discount

Kidney cancer, also known as renal cancer, is a type of cancer that starts in the cells in the kidney. The two most common types of kidney cancer are renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) of the renal pelvis. These names reflect the type of cell from which the cancer developed. The different types of kidney cancer (such as RCC and TCC) develop in different ways, meaning that the diseases have different long term outcomes, and need to be staged and treated in different ways. RCC is responsible for approximately 80% of primary renal cancers, and TCC accounts the majority of the remainder.

Scope of the Report:

This report focuses on the Kidney Cancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Biological therapies are drugs which are used to kill cancer cells or stop them from growing. Biological therapies are used to try to shrink or control advanced kidney cancer and help people to live longer. You may be given biological therapies for kidney cancer that has already spread, or is at high-risk of coming back after surgery.

The worldwide market for Kidney Cancer Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Bayer

Roche

GlaxoSmithKline

Novartis

Pfizer

Abbott Laboratories

Active Biotech

Amgen

Argos Therapeutics

ArQule

AVEO Pharmaceuticals

Bionomics

Bristol-Myers Squibb

Cerulean Pharma

Exelixis

Genentech

immatics biotechnologies

Immunicum

Ono Pharmaceutical

Onyx Therapeutics

Oxford BioMedica

Prometheus Laboratories

Seattle Genetics

Taiwan Liposome

Tracon Pharmaceuticals

Wilex

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Angiogenesis Inhibitors

mTOR Inhibitors

Monoclonal Antibodies

Cytokine Immunotherapy (IL-2)

Market Segment by Applications, can be divided into

Renal cell carcinoma (RCC)

Transitional cell carcinoma (TCC)

There are 15 Chapters to deeply display the global Kidney Cancer Drugs market.

Chapter 1, to describe Kidney Cancer Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Kidney Cancer Drugs, with sales, revenue, and price of Kidney Cancer Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Kidney Cancer Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Kidney Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Kidney Cancer Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Kidney Cancer Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Angiogenesis Inhibitors

1.2.2 mTOR Inhibitors

1.2.3 Monoclonal Antibodies

1.2.4 Cytokine Immunotherapy (IL-2)

1.3 Market Analysis by Applications

1.3.1 Renal cell carcinoma (RCC)

1.3.2 Transitional cell carcinoma (TCC)

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Bayer

2.1.1 Business Overview

2.1.2 Kidney Cancer Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Bayer Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Roche

2.2.1 Business Overview

2.2.2 Kidney Cancer Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Roche Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 GlaxoSmithKline

2.3.1 Business Overview

2.3.2 Kidney Cancer Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GlaxoSmithKline Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Kidney Cancer Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Pfizer

2.5.1 Business Overview

2.5.2 Kidney Cancer Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Abbott Laboratories

2.6.1 Business Overview

2.6.2 Kidney Cancer Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Abbott Laboratories Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Active Biotech

2.7.1 Business Overview

2.7.2 Kidney Cancer Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Active Biotech Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Amgen

2.8.1 Business Overview

2.8.2 Kidney Cancer Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Amgen Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Argos Therapeutics

2.9.1 Business Overview

2.9.2 Kidney Cancer Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Argos Therapeutics Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 ArQule

2.10.1 Business Overview

2.10.2 Kidney Cancer Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 ArQule Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 AVEO Pharmaceuticals

2.11.1 Business Overview

2.11.2 Kidney Cancer Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 AVEO Pharmaceuticals Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Bionomics

2.12.1 Business Overview

2.12.2 Kidney Cancer Drugs Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Bionomics Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Bristol-Myers Squibb

2.13.1 Business Overview

2.13.2 Kidney Cancer Drugs Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Bristol-Myers Squibb Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.14 Cerulean Pharma

2.14.1 Business Overview

2.14.2 Kidney Cancer Drugs Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Cerulean Pharma Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.15 Exelixis

2.15.1 Business Overview

2.15.2 Kidney Cancer Drugs Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Exelixis Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.16 Genentech

2.16.1 Business Overview

2.16.2 Kidney Cancer Drugs Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Genentech Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.17 immatics biotechnologies

2.17.1 Business Overview

2.17.2 Kidney Cancer Drugs Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 immatics biotechnologies Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.18 Immunicum

2.18.1 Business Overview

2.18.2 Kidney Cancer Drugs Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Immunicum Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.19 Ono Pharmaceutical

2.19.1 Business Overview

2.19.2 Kidney Cancer Drugs Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Ono Pharmaceutical Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.20 Onyx Therapeutics

2.20.1 Business Overview

2.20.2 Kidney Cancer Drugs Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Onyx Therapeutics Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.21 Oxford BioMedica

2.21.1 Business Overview

2.2.2 Kidney Cancer Drugs Type and Applications

2.21.2.1 Product A

2.21.2.2 Product B

2.21.3 Oxford BioMedica Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.22 Prometheus Laboratories

2.22.1 Business Overview

2.22.2 Kidney Cancer Drugs Type and Applications

2.22.2.1 Product A

2.22.2.2 Product B

2.22.3 Prometheus Laboratories Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.23 Seattle Genetics

2.23.1 Business Overview

2.23.2 Kidney Cancer Drugs Type and Applications

2.23.2.1 Product A

2.23.2.2 Product B

2.23.3 Seattle Genetics Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.24 Taiwan Liposome

2.24.1 Business Overview

2.24.2 Kidney Cancer Drugs Type and Applications

2.24.2.1 Product A

2.24.2.2 Product B

2.24.3 Taiwan Liposome Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.25 Tracon Pharmaceuticals

2.25.1 Business Overview

2.25.2 Kidney Cancer Drugs Type and Applications

2.25.2.1 Product A

2.25.2.2 Product B

2.25.3 Tracon Pharmaceuticals Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.26 Wilex

2.26.1 Business Overview

2.26.2 Kidney Cancer Drugs Type and Applications

2.26.2.1 Product A

2.26.2.2 Product B

2.26.3 Wilex Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Kidney Cancer Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Kidney Cancer Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Kidney Cancer Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Kidney Cancer Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Kidney Cancer Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Kidney Cancer Drugs Market Analysis by Regions

4.1 Global Kidney Cancer Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Kidney Cancer Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Kidney Cancer Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

4.5 South America Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

5 North America Kidney Cancer Drugs by Countries

5.1 North America Kidney Cancer Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Kidney Cancer Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Kidney Cancer Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

6 Europe Kidney Cancer Drugs by Countries

6.1 Europe Kidney Cancer Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Kidney Cancer Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Kidney Cancer Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

6.3 UK Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

6.4 France Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Kidney Cancer Drugs by Countries

7.1 Asia-Pacific Kidney Cancer Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Kidney Cancer Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Kidney Cancer Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

7.5 India Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

8 South America Kidney Cancer Drugs by Countries

8.1 South America Kidney Cancer Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Kidney Cancer Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Kidney Cancer Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Kidney Cancer Drugs by Countries

9.1 Middle East and Africa Kidney Cancer Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Kidney Cancer Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Kidney Cancer Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

10 Global Kidney Cancer Drugs Market Segment by Type

10.1 Global Kidney Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Kidney Cancer Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Kidney Cancer Drugs Revenue and Market Share by Type (2013-2018)

10.2 Angiogenesis Inhibitors Sales Growth and Price

10.2.1 Global Angiogenesis Inhibitors Sales Growth (2013-2018)

10.2.2 Global Angiogenesis Inhibitors Price (2013-2018)

10.3 mTOR Inhibitors Sales Growth and Price

10.3.1 Global mTOR Inhibitors Sales Growth (2013-2018)

10.3.2 Global mTOR Inhibitors Price (2013-2018)

10.4 Monoclonal Antibodies Sales Growth and Price

10.4.1 Global Monoclonal Antibodies Sales Growth (2013-2018)

10.4.2 Global Monoclonal Antibodies Price (2013-2018)

10.5 Cytokine Immunotherapy (IL-2) Sales Growth and Price

10.5.1 Global Cytokine Immunotherapy (IL-2) Sales Growth (2013-2018)

10.5.2 Global Cytokine Immunotherapy (IL-2) Price (2013-2018)

11 Global Kidney Cancer Drugs Market Segment by Application

11.1 Global Kidney Cancer Drugs Sales Market Share by Application (2013-2018)

11.2 Renal cell carcinoma (RCC) Sales Growth (2013-2018)

11.3 Transitional cell carcinoma (TCC) Sales Growth (2013-2018)

12 Kidney Cancer Drugs Market Forecast (2018-2023)

12.1 Global Kidney Cancer Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Kidney Cancer Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Kidney Cancer Drugs Market Forecast (2018-2023)

12.2.2 Europe Kidney Cancer Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Kidney Cancer Drugs Market Forecast (2018-2023)

12.2.4 South America Kidney Cancer Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Kidney Cancer Drugs Market Forecast (2018-2023)

12.3 Kidney Cancer Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Kidney Cancer Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Kidney Cancer Drugs Market Share Forecast by Type (2018-2023)

12.4 Kidney Cancer Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Kidney Cancer Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Kidney Cancer Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Kidney Cancer Drugs Picture

Table Product Specifications of Kidney Cancer Drugs

Figure Global Sales Market Share of Kidney Cancer Drugs by Types in 2017

Table Kidney Cancer Drugs Types for Major Manufacturers

Figure Angiogenesis Inhibitors Picture

Figure mTOR Inhibitors Picture

Figure Monoclonal Antibodies Picture

Figure Cytokine Immunotherapy (IL-2) Picture

Figure Kidney Cancer Drugs Sales Market Share by Applications in 2017

Figure Renal cell carcinoma (RCC) Picture

Figure Transitional cell carcinoma (TCC) Picture

Figure United States Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure France Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure UK Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure China Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure India Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Kidney Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Table Bayer Basic Information, Manufacturing Base and Competitors

Table Bayer Kidney Cancer Drugs Type and Applications

Table Bayer Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Kidney Cancer Drugs Type and Applications

Table Roche Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Kidney Cancer Drugs Type and Applications

Table GlaxoSmithKline Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Kidney Cancer Drugs Type and Applications

Table Novartis Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Kidney Cancer Drugs Type and Applications

Table Pfizer Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table Abbott Laboratories Kidney Cancer Drugs Type and Applications

Table Abbott Laboratories Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Active Biotech Basic Information, Manufacturing Base and Competitors

Table Active Biotech Kidney Cancer Drugs Type and Applications

Table Active Biotech Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Kidney Cancer Drugs Type and Applications

Table Amgen Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Argos Therapeutics Basic Information, Manufacturing Base and Competitors

Table Argos Therapeutics Kidney Cancer Drugs Type and Applications

Table Argos Therapeutics Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table ArQule Basic Information, Manufacturing Base and Competitors

Table ArQule Kidney Cancer Drugs Type and Applications

Table ArQule Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AVEO Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table AVEO Pharmaceuticals Kidney Cancer Drugs Type and Applications

Table AVEO Pharmaceuticals Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bionomics Basic Information, Manufacturing Base and Competitors

Table Bionomics Kidney Cancer Drugs Type and Applications

Table Bionomics Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors

Table Bristol-Myers Squibb Kidney Cancer Drugs Type and Applications

Table Bristol-Myers Squibb Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Cerulean Pharma Basic Information, Manufacturing Base and Competitors

Table Cerulean Pharma Kidney Cancer Drugs Type and Applications

Table Cerulean Pharma Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Exelixis Basic Information, Manufacturing Base and Competitors

Table Exelixis Kidney Cancer Drugs Type and Applications

Table Exelixis Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Genentech Basic Information, Manufacturing Base and Competitors

Table Genentech Kidney Cancer Drugs Type and Applications

Table Genentech Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table immatics biotechnologies Basic Information, Manufacturing Base and Competitors

Table immatics biotechnologies Kidney Cancer Drugs Type and Applications

Table immatics biotechnologies Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Immunicum Basic Information, Manufacturing Base and Competitors

Table Immunicum Kidney Cancer Drugs Type and Applications

Table Immunicum Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Ono Pharmaceutical Kidney Cancer Drugs Type and Applications

Table Ono Pharmaceutical Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Onyx Therapeutics Basic Information, Manufacturing Base and Competitors

Table Onyx Therapeutics Kidney Cancer Drugs Type and Applications

Table Onyx Therapeutics Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Oxford BioMedica Basic Information, Manufacturing Base and Competitors

Table Oxford BioMedica Kidney Cancer Drugs Type and Applications

Table Oxford BioMedica Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Prometheus Laboratories Basic Information, Manufacturing Base and Competitors

Table Prometheus Laboratories Kidney Cancer Drugs Type and Applications

Table Prometheus Laboratories Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Seattle Genetics Basic Information, Manufacturing Base and Competitors

Table Seattle Genetics Kidney Cancer Drugs Type and Applications

Table Seattle Genetics Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Taiwan Liposome Basic Information, Manufacturing Base and Competitors

Table Taiwan Liposome Kidney Cancer Drugs Type and Applications

Table Taiwan Liposome Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Tracon Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Tracon Pharmaceuticals Kidney Cancer Drugs Type and Applications

Table Tracon Pharmaceuticals Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Wilex Basic Information, Manufacturing Base and Competitors

Table Wilex Kidney Cancer Drugs Type and Applications

Table Wilex Kidney Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Kidney Cancer Drugs Sales by Manufacturer (2016-2017)

Figure Global Kidney Cancer Drugs Sales Market Share by Manufacturer in 2016

Figure Global Kidney Cancer Drugs Sales Market Share by Manufacturer in 2017

Table Global Kidney Cancer Drugs Revenue by Manufacturer (2016-2017)

Figure Global Kidney Cancer Drugs Revenue Market Share by Manufacturer in 2016

Figure Global Kidney Cancer Drugs Revenue Market Share by Manufacturer in 2017

Figure Top 3 Kidney Cancer Drugs Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Kidney Cancer Drugs Manufacturer (Revenue) Market Share in 2017

Figure Global Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Global Kidney Cancer Drugs Revenue and Growth Rate (2013-2018)

Table Global Kidney Cancer Drugs Sales by Regions (2013-2018)

Table Global Kidney Cancer Drugs Sales Market Share by Regions (2013-2018)

Table Global Kidney Cancer Drugs Revenue by Regions (2013-2018)

Figure Global Kidney Cancer Drugs Revenue Market Share by Regions in 2013

Figure Global Kidney Cancer Drugs Revenue Market Share by Regions in 2017

Figure North America Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Europe Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure South America Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure North America Kidney Cancer Drugs Revenue and Growth Rate (2013-2018)

Table North America Kidney Cancer Drugs Sales by Countries (2013-2018)

Table North America Kidney Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure North America Kidney Cancer Drugs Sales Market Share by Countries in 2013

Figure North America Kidney Cancer Drugs Sales Market Share by Countries in 2017

Table North America Kidney Cancer Drugs Revenue by Countries (2013-2018)

Table North America Kidney Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Kidney Cancer Drugs Revenue Market Share by Countries in 2013

Figure North America Kidney Cancer Drugs Revenue Market Share by Countries in 2017

Figure United States Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Canada Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Mexico Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Europe Kidney Cancer Drugs Revenue and Growth Rate (2013-2018)

Table Europe Kidney Cancer Drugs Sales by Countries (2013-2018)

Table Europe Kidney Cancer Drugs Sales Market Share by Countries (2013-2018)

Table Europe Kidney Cancer Drugs Revenue by Countries (2013-2018)

Figure Europe Kidney Cancer Drugs Revenue Market Share by Countries in 2016

Figure Europe Kidney Cancer Drugs Revenue Market Share by Countries in 2017

Figure Germany Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure UK Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure France Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Russia Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Italy Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Kidney Cancer Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Kidney Cancer Drugs Sales by Countries (2013-2018)

Table Asia-Pacific Kidney Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Kidney Cancer Drugs Sales Market Share by Countries 2017

Table Asia-Pacific Kidney Cancer Drugs Revenue by Countries (2013-2018)

Figure Asia-Pacific Kidney Cancer Drugs Revenue Market Share by Countries 2017

Figure China Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Japan Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Korea Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure India Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Southeast Asia Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure South America Kidney Cancer Drugs Revenue and Growth Rate (2013-2018)

Table South America Kidney Cancer Drugs Sales by Countries (2013-2018)

Table South America Kidney Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure South America Kidney Cancer Drugs Sales Market Share by Countries in 2017

Table South America Kidney Cancer Drugs Revenue by Countries (2013-2018)

Table South America Kidney Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Kidney Cancer Drugs Revenue Market Share by Countries in 2017

Figure Brazil Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Argentina Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Colombia Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Kidney Cancer Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Kidney Cancer Drugs Sales by Countries (2013-2018)

Table Middle East and Africa Kidney Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Kidney Cancer Drugs Sales Market Share by Countries in 2017

Table Middle East and Africa Kidney Cancer Drugs Revenue by Countries (2013-2018)

Table Middle East and Africa Kidney Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Kidney Cancer Drugs Revenue Market Share by Countries in 2013

Figure Middle East and Africa Kidney Cancer Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure UAE Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Egypt Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Nigeria Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Figure South Africa Kidney Cancer Drugs Sales and Growth Rate (2013-2018)

Table Global Kidney Cancer Drugs Sales by Type (2013-2018)

Table Global Kidney Cancer Drugs Sales Share by Type (2013-2018)

Table Global Kidney Cancer Drugs Revenue by Type (2013-2018)

Table Global Kidney Cancer Drugs Revenue Share by Type (2013-2018)

Figure Global Angiogenesis Inhibitors Sales Growth (2013-2018)

Figure Global Angiogenesis Inhibitors Price (2013-2018)

Figure Global mTOR Inhibitors Sales Growth (2013-2018)

Figure Global mTOR Inhibitors Price (2013-2018)

Figure Global Monoclonal Antibodies Sales Growth (2013-2018)

Figure Global Monoclonal Antibodies Price (2013-2018)

Figure Global Cytokine Immunotherapy (IL-2) Sales Growth (2013-2018)

Figure Global Cytokine Immunotherapy (IL-2) Price (2013-2018)

Table Global Kidney Cancer Drugs Sales by Application (2013-2018)

Table Global Kidney Cancer Drugs Sales Share by Application (2013-2018)

Figure Global Transitional cell carcinoma (TCC) Sales Growth (2013-2018)

Figure Global Kidney Cancer Drugs Sales, Revenue and Growth Rate (2018-2023)

Table Global Kidney Cancer Drugs Sales Forecast by Regions (2018-2023)

Table Global Kidney Cancer Drugs Market Share Forecast by Regions (2018-2023)

Figure North America Sales Kidney Cancer Drugs Market Forecast (2018-2023)

Figure Europe Sales Kidney Cancer Drugs Market Forecast (2018-2023)

Figure Asia-Pacific Sales Kidney Cancer Drugs Market Forecast (2018-2023)

Figure South America Sales Kidney Cancer Drugs Market Forecast (2018-2023)

Figure Middle East and Africa Sales Kidney Cancer Drugs Market Forecast (2018-2023)

Table Global Kidney Cancer Drugs Sales Forecast by Type (2018-2023)

Table Global Kidney Cancer Drugs Market Share Forecast by Type (2018-2023)

Table Global Kidney Cancer Drugs Sales Forecast by Application (2018-2023)

Table Global Kidney Cancer Drugs Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Purchase Options

Single User License $3480 Multiple $5220 Corporate $6960

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

Publish Date: November 14, 2017
$5370

View Details

Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

Publish Date: July 20, 2017
$5370

View Details

Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

Publish Date: April 24, 2017
$5370

View Details

Client Testimonials

Your team has worked hard to help and to provide our research needs to fulfill our significant initiatives...

Maria

-Researcher

The report on EAA resins was detailed and informative. However, we were hopeful to discover a Chinese producer ...

David

-President Protech Oxyplast Group

Thanks the attached report is perfect and accurate, but I was wondering if you can show the price trend in one year...

Global Kidney Cancer Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara